First, the specific mechanism of CDCA3 on CD8+T cells and its influence on immunotherapy of renal cell carcinoma need to be further explored; second, we have proved that CDCA3 can block the cell cycle, but there is no further study on the biological mechanism. This evidence concerns the gene CD8A and hereditary clear cell renal cell carcinoma.